Literature DB >> 9834060

Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue.

G M Spiekermann1, C Nagler-Anderson.   

Abstract

The toxicity of the staphylococcal enterotoxins (SEs) has been linked to the activation of large numbers of T cells in the peripheral lymphoid tissues. Because the primary manifestations of foodborne enterotoxic poisoning are associated with the gastrointestinal tract, we have compared the responses of T cells in the gut-associated lymphoid tissue and in the periphery to intragastric (i.g.) and i.p. administration of SEB. Intraperitoneal SEB results in an early expansion of peripheral Vbeta8+ T cells and Th1 cytokine secretion followed by deletion at 7-10 days. We found that i.g. SEB rapidly (within 4 h) leads to the expansion and activation of Vbeta8+ T cells in the Peyer's patch and mesenteric lymph nodes. Analysis of cytokine mRNA in purified Vbeta8+ T cells by competitive RT-PCR showed that, 4 h after i.g. SEB, the induction of mRNA for IL-2 and IFN-gamma is about 10-fold greater in mucosal than in peripheral lymphoid tissue. Our results show that activated mucosal T cells expand and up-regulate cytokine mRNA in response to luminal exposure to SEB, suggesting a role for the gut-associated lymphoid tissue in the gastrointestinal manifestations of enterotoxic poisoning.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834060

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Identification of a transcytosis epitope on staphylococcal enterotoxins.

Authors:  Jeffrey W Shupp; Marti Jett; Carol H Pontzer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.

Authors:  B G Stiles; A R Garza; R G Ulrich; J W Boles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 3.  Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.

Authors:  Amanda J Brosnahan; Patrick M Schlievert
Journal:  FEBS J       Date:  2011-05-19       Impact factor: 5.542

4.  Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes.

Authors:  A I Roberts; R S Blumberg; A D Christ; R E Brolin; E C Ebert
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

5.  Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.

Authors:  Onyinye I Iweala; Donald W Smith; Kabir S Matharu; Isabel Sada-Ovalle; Deanna D Nguyen; Rosemarie H Dekruyff; Dale T Umetsu; Samuel M Behar; Cathryn R Nagler
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

6.  Induction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease.

Authors:  Qing Cai; Xiaoping Du; Bin Zhou; Chun Cai; Mohammad Habiby Kermany; Taijune Yoo
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2009-04-10       Impact factor: 1.538

7.  Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitis.

Authors:  Armando Heriazon; Pengfei Zhou; Rajka Borojevic; Katharina Foerster; Catherine J Streutker; Terry Ng; Kenneth Croitoru
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

Review 8.  Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2010-07-29       Impact factor: 4.546

9.  Concurrent exposure to microbial products and food antigens triggers initiation of food allergy.

Authors:  Xiao Chen; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2009-06

Review 10.  Superantigens in human disease.

Authors:  A Bernal; T Proft; J D Fraser; D N Posnett
Journal:  J Clin Immunol       Date:  1999-05       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.